You are here: Industry Insights > gene therapy

News List

Thermo Fisher Scientific Expands Viral Vector Mfg. Capacity contractpharma
May 12, 2020
$180M project will more than double commercial capacity in Plainville, MA to support the development and manufacture of gene therapies and vaccines.
Magenta, AVROBIO to evaluate antibody drug conjugate MGTA-117 pharmaceutical-technology
May 08, 2020
Magenta Therapeutics has signed an agreement with AVROBIO to evaluate the potential utility of its novel targeted antibody-drug conjugate (ADC) MGTA-117 as a potential conditioning regimen for lentiviral gene therapies.
MRC and LifeArc announce grants for Gene Therapy Innovation Hubs in UK europeanpharmaceuticalreview
May 08, 2020
The UK MRC and LifeArc are making £16 million available as grants to fund the establishment of Gene Therapy Innovation Hubs to improve resources for researchers and manufacturers.
Avrobio and Magenta Therapeutics Collaborate contractpharma
May 07, 2020
Evaluate targeted antibody-drug conjugate as a potential conditioning regimen for lentiviral gene therapies.
LifeArc, MRC create £16m fund to set up gene therapy hubs pharmatimes
May 06, 2020
The Medical Research Council (MRC) and independent medical research charity LifeArc are streaming £16 million into establishing a network of gene therapy innovation hubs.
Evotec, Takeda Enter Long-Term Research Alliance contractpharma
April 07, 2020
Evotec will support multiple Takeda programs targeting oncology, rare diseases, neuroscience and gastroenterology.
AveXis’ Zolgensma gene therapy yields desired results in SMA trials pharmaceutical-business-review
March 27, 2020
AveXis said that a one-time infusion of Zolgensma (onasemnogene abeparvovec-xioi) delivered rapid, substantial, and clinically meaningful therapeutic benefit ...
Codexis Signs Strategic Collaboration, License Agreement with Takeda americanpharmaceuticalreview
March 27, 2020
Codexis has announced the signing of a strategic collaboration and license agreement with Takeda Pharmaceutical for the research and development of novel gene therapies ...
Takeda partners with Codexis on gene therapies for rare diseases pharmaceutical-technology
March 25, 2020
Takeda Pharmaceutical has signed a strategic collaboration and licence agreement with biotherapeutics developer Codexis to research and create gene therapies for rare disorders.
Codexis, Takeda Sign Gene Therapy Collaboration contractpharma
March 25, 2020
Partnership to leverage Codexis’ protein engineering platform to advance novel gene therapies for rare genetic disorders。

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page